NCT05837130View on ClinicalTrials.gov

Non-drug Treatment Study in Parkinson's Disease Patients and Healthy Volunteers to Collect Biological Samples in Order to Assess ex Vivo the Activity of Candidate Therapies and Develop Novel Analytical Methods for Biomarkers

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

November 29, 2022

Study Completion Date

November 29, 2022

Conditions
Parkinson Disease
Interventions
OTHER

Blood sample collection and an optional cerebrospinal fluid (CSF) collection

No study drug will be administered to study participants.

OTHER

Blood sample collection

No study drug will be administered to study participants.

Trial Locations (4)

31000

Centre Hospitalo-Universitaire Toulouse, Toulouse

38700

Centre Hospitalo-Universitaire Grenoble Alpes, La Tronche

59000

Centre Hospitalo-Universitaire Lille, Lille

75013

Hopital La Pitié Salpétrière-Institut du Cerveau et de la Moelle Epinière-CIC Neurosciences, Paris

All Listed Sponsors
lead

Servier

INDUSTRY